Evogene Ltd EVGN
NASDAQ · United States · Health Technology
$0.4250-0.01 (-2.43%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-18 | -0.14 | -0.27 | +48.1% | $347.00K | +6.8% | +7.1%$0.56→$0.60 |
| Q1 2026 | 2026-05-20 | -0.61 | -0.27 | -125.9% | — | — | -6.8%$0.74→$0.69 |
| Q4 2025 | 2026-03-05 | -0.62 | -0.26 | -138.5% | — | — | -8.3%$0.84→$0.77 |
| Q3 2025 | 2025-11-20 | -0.46 | -0.41 | -12.2% | — | — | -3.4%$1.17→$1.13 |
| Q2 2025 | 2025-08-19 | -0.50 | -0.63 | +20.6% | — | — | — |
| Q1 2025 | 2025-05-21 | -0.38 | -0.50 | +24.0% | — | — | — |
| Q4 2024 | 2025-03-06 | 0.06 | -0.72 | +108.3% | — | — | — |
| Q3 2024 | 2024-11-21 | -1.31 | -1.01 | -29.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.